Veradigm (NASDAQ:MDRX) Trading Up 8.9% – Still a Buy?

Veradigm Inc. (NASDAQ:MDRX) shares traded up 8.9% during trading on Wednesday . The stock traded as high as $4.90 and last traded at $4.90. 11,749 shares changed hands during trading, a decline of 93% from the average session volume of 167,985 shares. The stock had previously closed at $4.50.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised shares of Veradigm to a “hold” rating in a research note on Saturday, March 7th.

Veradigm Stock Performance

The stock’s 50-day simple moving average is $4.60 and its two-hundred day simple moving average is $4.65. The stock has a market cap of $555.04 million, a price-to-earnings ratio of 23.25 and a beta of 0.55.

Veradigm Company Profile

Veradigm, Inc (NASDAQ: MDRX) is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company’s offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm’s product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.